METABOLISM OF ANTIHYPERTENSIVE AGENT 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER

被引：29
|
作者：
WALKENSTEIN, SS [1 ]
INTOCCIA, AP [1 ]
FLANAGAN, TL [1 ]
HWANG, B [1 ]
FLINT, D [1 ]
WEINSTOCK, J [1 ]
VILLANI, AJ [1 ]
BLACKBURN, D [1 ]
GREEN, H [1 ]
机构：
[1] SK&F LABS, RES & DEV DIV, PHILADELPHIA, PA 19101 USA
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1973年 / 62卷 / 04期
关键词：
D O I：
10.1002/jps.2600620407
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：580 / 584
页数：5
相关论文
共 50 条
  • [21] DETERMINATION OF 2,6-DIMETHYL-4-(2'-NITROSOPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIMETHYLESTER IN NIFEDIPINE BY DERIVATIVE UV-SPECTROPHOTOMETRY IN BULK MATERIAL AND PHARMACEUTICAL FORMS
    CARLUCCI, G
    COLANZI, A
    MAZZEO, P
    FARMACO, 1990, 45 (06): : 751 - 755
  • [22] INFLUENCE OF THE ESTER FUNCTION ON THE VASODILATING ACTIVITY OF 1,4-DIHYDRO-2,6-DIMETHYL-4-NITROPHENYLPYRIDINE-3,5-DICARBOXYLATES
    BOSSERT, F
    HORSTMANN, H
    MEYER, H
    VATER, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (02): : 226 - 229
  • [23] SYNTHESIS AND COMPARATIVE PHARMACOLOGICAL STUDIES OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)PYRIDINE-3,5-DICARBOXYLATES WITH NON-IDENTICAL ESTER FUNCTIONS
    MEYER, H
    BOSSERT, F
    WEHINGER, E
    STOEPEL, K
    VATER, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-1 (03): : 407 - 409
  • [24] Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3,5-pyridinedicarboxylates
    Ramesh, M
    Matowe, WC
    Wolowyk, MW
    Knaus, EE
    ARCHIV DER PHARMAZIE, 1999, 332 (11) : 385 - 388
  • [25] SYNTHESIS AND CONFIGURATIONAL ASSIGNMENT OF METHYL 3-NITROOXYPROPYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)PYRIDINE-3,5-DICARBOXYLATE
    OGAWA, T
    MATSUMOTO, K
    YOKOO, C
    HATAYAMA, K
    KITAMURA, K
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1993, (04): : 525 - 528
  • [26] SYNTHESIS OF ASYMMETRIC 4-ARYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLATES WITH VASODILATING AND ANTIHYPERTENSIVE ACTIVITIES
    OHNO, S
    KOMATSU, O
    MIZUKOSHI, K
    ICHIHARA, K
    NAKAMURA, Y
    MORISHIMA, T
    SUMITA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (04) : 1589 - 1606
  • [27] THE STRUCTURE OF ETHYL ALLYL 1,4-DIHYDRO-2,6-DIMETHYL-4-[4-(4H-4-OXO-1-BENZOPYRAN-2-YL)PHENYL]-3,5-PYRIDINE DICARBOXYLATE
    KENDI, E
    OZBEY, S
    TUNCBILEK, M
    ERTAN, R
    FUN, HK
    YIP, BC
    JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 1994, 24 (11) : 747 - 751
  • [28] Dibutyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, diisobutyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate and di-tert-butyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
    Rowan, KR
    Holt, EM
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1996, 52 : 2207 - 2212
  • [29] The study of the photo transformation of dimethyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pitydinecarboxilate (Nifedipin)
    Maranescu, B
    Szabadai, Z
    Cosmiuc, C
    Ilia, G
    REVISTA DE CHIMIE, 2005, 56 (06): : 663 - 666
  • [30] Diethyl 2,6-dimethyl-4-[4-(3-phenylacryloyloxy) phenyl]-1,4-dihydropyridine-3,5-dicarboxylate hemihydrate
    Sharmila, P.
    Kumar, C. Suresh
    Ananth, Karthik
    Narasimhan, S.
    Aravindhan, S.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O389 - +
12345